TRANSCRIPT

Q4 2023 — Earnings call introductory remarks

Q4 2023PDF · 7 pages133 KB
1
CME Group 4Q 2023 Earnings Introductory Script
February 14, 2024
Adam Minick
Good morning, and I hope you are all doing well today. We released our executive
commentary earlier today, which provides extensive details on the fourth quarter
and full year of 2023 which we will be discussing on this call. I will start with the
safe harbor language, then I'll turn it over to Terry.
Statements made on this call and in the other reference documents on our
website that are not historical facts are forward-looking statements. These
statements are not guarantees of future performance. They involve risks,
uncertainties and assumptions that are difficult to predict. Therefore, actual
outcomes and results may differ materially from what is expressed or implied in
any statement. Detailed information about factors that may affect our
performance can be found in the filings with the SEC, which are on our website.
Lastly, on the final page of the earnings release, you will see a reconciliation
between GAAP and non-GAAP measures.
With that, I’ll turn the call over to Terry.

-- 1 of 7 --

2
Terrence Duffy
Thanks Adam and thank you all for joining us this morning. I’m going start by
giving a little color on the broader environment. Following that, Lynne will provide
an overview of our financial results and our 2024 guidance. In addition to Lynne,
we have other members of our management team present to answer questions
after the prepared remarks.
Early last year, I referred to 2023 as a new Age of Uncertainty, and that
uncertainty extended throughout the year. We experienced continued inflation,
rising costs of capital, increasing geopolitical tensions, and shifting perceptions
around the Fed’s interest rate policy. All of these factors contributed to our
customers’ growing needs for risk management, capital efficiencies and demand
for our products.
Following the very strong performance of our business in 2022 and 2023, we have
seen the speculation that our Interest Rates business could face headwinds based
on the expectation that the Fed will start to lower interest rates this year.
In my 40+ years in the industry, I’ve observed that regardless of whether rates are
going up or down, our volumes are typically higher during periods when the
change of rates is uncertain, as is the case today. I’ve never seen such a disparity

-- 2 of 7 --

3
in opinions on what the Fed may or may not do, and I believe that is a tailwind for
CME Group and our rates products.
I mentioned earlier that our interest rates volume was up 16% in 2023 with 4 Fed
rate hikes during the first half of the year, building off record volume levels in
2022. In contrast to the view that a rising rate environment is optimal for our
interest rates complex, our volume growth actually accelerated since the Fed
stopped raising rates in July of last year. In the six months from August of 2023
through January 2024, our rates volume is up 24% year-over-year.
I would also like to comment on the dynamics in the crude oil marketplace,
following the Russia/Ukraine war and other geopolitical factors that influenced the
price of energy. WTI has become even more relevant to customers in Europe and
Asia and cemented its position as the primary reference price for crude oil
globally. As the primary market for WTI trading, we continue to generate growth
and expand end-user client participation through developing and investing in new
contracts, such as CME Group’s Argus Gulf Coast contract. In a very short period of
time, these contracts have generated significant commercial participation, with
current open interest over 500K.
As indicated by the open interest, it’s clear that commercial participants prefer
CME Group’s Argus Gulf Coast contract. We continue to remain focused on the

-- 3 of 7 --

4
growth of these contracts along with creating capital and technological efficiencies
in the entire suite of CME Group’s energy complex. This anchors CME Group as the
global leader in WTI.
Moving into 2024, we continue to see a wide range of views as it relates to the
health of the global economy – whether it’s inflation, unemployment, or monetary
policy. Also, there are ongoing geopolitical tensions and supply chain disruptions
continuing in certain parts of the world. Additionally, we’re approaching political
elections in over 60 countries this year. The uncertainty of those elections – and
the politics that could come from that are basically unknown to all, which only
leads to market participants continuing to manage risk.
All that being said, 2024 is still very much in the Age of Uncertainty and our
products remain critical risk management tools for our customers. We have seen
this reflected in our strong start to 2024 where we delivered our highest January
average daily volume in our history of 25.2 million, up 16% relative to last year.
I’ll now turn the call over to Lynne to review our financial results.

-- 4 of 7 --

5
Lynne Fitzpatrick
Thanks, Terry and thank you all for joining us this morning. In addition to the
volume records Terry discussed, we delivered record financial results in 2023. Our
revenue of $5.6 billion grew 11% compared to 2022. Our annual adjusted
expenses, excluding license fees, were approximately $1.526 billion including $56
million related to our cloud migration. In aggregate, our adjusted operating
expenses were $9 million below our annual guidance. Our adjusted operating
margins for the year expanded to 66.9%, up over 200 basis points from 2022. We
delivered $3.4 billion in adjusted net income resulting in 17% earnings per share
growth for the year.
During the fourth quarter, CME Group generated more than $1.4 billion in
revenue, a 19% increase from Q4 2022 with average daily volume up 17%. Market
data revenue grew 9% from last year to $167 million. Expenses were very carefully
managed and on an adjusted basis were $490 million for the quarter and $393
million, excluding license fees and $16 million in cloud migration costs. CME Group
had an adjusted effective tax rate of 21.7%, which resulted in adjusted net income
of $865 million. Our adjusted EPS attributable to common shareholders was $2.37,
up 23% from the fourth quarter last year, and represented our 10th consecutive
quarter of double digits earnings growth.

-- 5 of 7 --

6
Capital expenditures for the fourth quarter were approximately $23 million and
cash at the end of the year was $3.1 billion. CME Group declared over $3.5 billion
of dividends during 2023, including the annual variable dividend of $1.9 billion
which was paid in January.
Turning to 2024 guidance, we expect total adjusted operating expenses, excluding
license fees but including cloud migration expenses, to be approximately $1.585
billion.
Total capital expenditures net of leasehold improvement allowances are expected
to be approximately $85 million, and the adjusted effective tax rate should come
in between 23% and 24%.
Finally, in November, we announced transaction fee adjustments, which became
effective February 1st . Assuming similar trading patterns as 2023, the fee
adjustments would increase futures and options transaction revenue
approximately 1.5%-2%. 	Taken in aggregate with the fee changes for market data
and non-cash collateral which took effect January 1st , the fee adjustments would
increase total revenue by approximately 2.5%-3% on similar activity to 2023.

-- 6 of 7 --

7
In summary, we are very proud of the results we were able to deliver as a firm this
year, driving 11% revenue growth and 17% adjusted earnings growth in 2023 from
our previous record year of 2022.
We'd now like to open up the call for your questions. Thank you.
Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of
future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results
may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue
reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as
a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition
by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing
entities; our ability to keep pace with rapid technological developments, including our ability to complete the development,
implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that
such technology is not vulnerable to security risks; our ability to continue introducing competitive new products and services on a timely,
cost-effective basis, including through our electronic trading capabilities, and our ability to maintain the competitiveness of our existing
products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to maintain existing
customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and
globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies
with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial
and operational resources from us or our customers; the costs associated with protecting our intellectual property rights and our ability
to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result
of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the
products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or
participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity
risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy
the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk
management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect
our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party
providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology
used by our third-party providers and third-party providers that our clients rely on; volatility in commodity, equity and fixed income
prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and
foreign exchange rates; economic, social, political and market conditions, including the volatility of the capital and credit markets and
the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases
in contract volume and order transaction traffic and to implement enhancements without failure or degradation of the performance of
our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage
the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments and alliances, including
those associated with the performance of our joint ventures with S&P Dow Jones (S&P Dow Jones Indices LLC) in index services and
in trade processing/post trade services (OSTTRA), our primary business and distribution partners’ actions and our partnership with
Google Cloud; variances in earnings on cash accounts and collateral that our clearing house holds for its clients; impact of CME Group
pricing and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial
impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our
indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or
concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options
transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes
in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a
detailed discussion and additional information concerning these and other factors that might affect our performance, see our other
recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the Securities
and Exchange Commission ("SEC") on February 27, 2023, under the caption "Risk Factors".

-- 7 of 7 --